Adamis Pharmaceuticals Corp — Form D

Adamis Pharmaceuticals Corp of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-06. The offering totals $6.1M, of which $6.1M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Meera J DesaiDirectorSan Diego, CA
Ebrahim J VersiDirectorSan Diego, CA
Ebrahim J VersiExecutive OfficerSan Diego, CA
Vickie S ReedDirectorSan Diego, CA
Jannine S VersiDirectorSan Diego, CA
David C BenedictoExecutive OfficerSan Diego, CA
Ronald B MossExecutive OfficerSAN DIEGO, CA
David J MarguglioDirectorSAN DIEGO, CA
David J MarguglioExecutive OfficerSAN DIEGO, CA
Richard C WilliamsDirectorSAN DIEGO, CA
Karen K DanielsDirectorSAN DIEGO, CA
Karen K DanielsExecutive OfficerSAN DIEGO, CA
Roshawn C BluntDirectorSAN DIEGO, CA
Dennis J CarloDirectorSAN DIEGO, CA
Dennis J CarloExecutive OfficerSAN DIEGO, CA
Robert O HopkinsDirectorSAN DIEGO, CA
Robert O HopkinsExecutive OfficerSAN DIEGO, CA
Howard C BirndorfDirectorSAN DIEGO, CA
Craig A JohnsonExecutive OfficerSan Diego, CA
Kenneth M CohenDirectorSAN DIEGO, CA
Tina S Nova, Ph. D.DirectorSAN DIEGO, CA
Tina S Nova, Ph. D.Executive OfficerSAN DIEGO, CA
Thomas K MollExecutive OfficerSan Diego, CA
Craig S JohnsonDirectorSAN DIEGO, CA
Tina S Nova, Ph.DDirectorSAN DIEGO, CA

Other filings by this issuer (8)

FiledFormOfferingSold
2023-06-12D
2022-07-07D$300K$300K
2020-06-30D$590K$590K
2013-07-11D$6.5M$6.5M
2013-04-24D$575K$575K
2012-07-09D$1.0M$1.0M
2012-04-06D$3.3M$3.3M
2010-11-23D$5.0M

More